1h Free Analyst Time
The insulin market is forecasted to grow by USD 1.29 billion during 2023-2028, accelerating at a CAGR of 1.38% during the forecast period. The report on the insulin market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of diabetes, increasing exposure to risk factors that lead to diabetes, and favorable government initiatives.
The insulin market is segmented as below:
By Type
- Insulin analog
- Human insulin
By Distribution Channel
- Retail pharmacies
- Hospitals
- Online pharmacies
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the insulin market covers the following areas:
- Insulin market sizing
- Insulin market forecast
- Insulin market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global insulin market: AdvaCare Pharma, ASP Healthcare Pty Ltd., B.Braun SE, Becton Dickinson and Co., Biocon Ltd., Cardinal Health Inc., CODAN Medizinische Gerate GmbH and Co KG, Eli Lilly and Co., Gerresheimer AG, Gulf Pharmaceutical Industries, Healthwarehouse.com Inc., Hi Tech Medics Pvt Ltd., Hindustan Syringes and Medical Devices Ltd., Mayo Foundation for Medical Education and Research, Nipro Corp., Novo Nordisk AS, Pfizer Inc., Sanofi SA, UltiMed Inc., and Wockhardt Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advances in insulin delivery systems."
According to the report, one of the major drivers for this market is the growing prevalence of diabetes.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AdvaCare Pharma
- ASP Healthcare Pty Ltd.
- B.Braun SE
- Becton Dickinson and Co.
- Biocon Ltd.
- Cardinal Health Inc.
- CODAN Medizinische Gerate GmbH and Co KG
- Eli Lilly and Co.
- Gerresheimer AG
- Gulf Pharmaceutical Industries
- Healthwarehouse.com Inc.
- Hi Tech Medics Pvt Ltd.
- Hindustan Syringes and Medical Devices Ltd.
- Mayo Foundation for Medical Education and Research
- Nipro Corp.
- Novo Nordisk AS
- Pfizer Inc.
- Sanofi SA
- UltiMed Inc.
- Wockhardt Ltd.
